![Kristine Ball](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kristine Ball
Directeur/Bestuurslid bij ATRECA, INC.
Actieve functies van Kristine Ball
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATRECA, INC. | Directeur/Bestuurslid | 20-05-2020 | - |
Independent Dir/Board Member | 20-05-2020 | - | |
Antiva Biosciences, Inc.
![]() Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Algemeen Directeur | 27-04-2023 | - |
Loopbaan van Kristine Ball
Eerdere bekende functies van Kristine Ball
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FORTY SEVEN, INC. | Directeur/Bestuurslid | 20-02-2018 | 07-04-2020 |
Independent Dir/Board Member | 20-02-2018 | 07-04-2020 | |
VYNE THERAPEUTICS INC. | Financieel Directeur/CFO | 01-09-2017 | 01-03-2020 |
RELYPSA INC | Financieel Directeur/CFO | 10-12-2012 | 01-01-2016 |
EXELIXIS, INC. | Financieel Directeur/CFO | 01-01-2000 | 01-01-2005 |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-1998 | 01-01-2000 |
Soteria Biotherapeutics, Inc.
![]() Soteria Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Soteria Biotherapeutics, Inc. develops next-generation immunotherapies. Its development allows to control the activity of immunomodulatory therapeutics such as bi-specific T-cell engagers (BiTEs) and CAR T-cells.The company was founded by Zachary Hill and Alexander Martinko and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-09-2020 | - |
Algemeen Directeur | 01-09-2020 | - | |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Hoofd Administratief Officier | 01-02-2005 | - |
Financieel Directeur/CFO | 01-02-2005 | - |
Opleiding van Kristine Ball
Babson College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Zweden | 2 |
Operationeel
Director of Finance/CFO | 4 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sectoraal
Health Technology | 9 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
EXELIXIS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Relypsa, Inc.
![]() Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Menlo Therapeutics, Inc.
![]() Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
Forty Seven, Inc.
![]() Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Atreca, Inc.
![]() Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |
Soteria Biotherapeutics, Inc.
![]() Soteria Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Soteria Biotherapeutics, Inc. develops next-generation immunotherapies. Its development allows to control the activity of immunomodulatory therapeutics such as bi-specific T-cell engagers (BiTEs) and CAR T-cells.The company was founded by Zachary Hill and Alexander Martinko and is headquartered in San Francisco, CA. | Health Technology |
Antiva Biosciences, Inc.
![]() Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Kristine Ball
- Ervaring